Surprise Me!
Novo Nordisk CSO on New Obesity Shot Results and Drug Pipeline
2026-02-23
3
Dailymotion
Related Videos
Novo Nordisk Shares Jump After CEO Predicts Wegovy Recovery as Compounded Drugs Exit U.S. Market
Ten Pharma Firms Form Non-profit to Speed Up New Drug Trials; InBalance Health Launches New Nutrition Bars; Novo Nordisk Ranks High on Carbon Disclosure Project - Health Minute for September 27, 2012
Trump Announces Historic Drug Deal With Eli Lilly and Novo Nordisk Through TrumpRx Portal | APT
AI Expansion: Novo Nordisk Partners with AWS for Enhanced Drug Research
Novo Nordisk Shares Pop as New Obesity Drug Candidate Shows Impressive 13.1% Weight Loss in Early Trials
Diabetes Drug From Nordisk Also Cuts Heart Risks by 13 Percent
Novo Nordisk earnings: sales of weight-loss drug Wegovy lower than expected
Novo Nordisk cuts supply of obesity drug Wegovy in the US due to surging demand
Novo Nordisk reports Q1 profits o $3.65 BN as demand for weightloss drug soars
'Stop Ripping Us Off.' Senate Grills Novo Nordisk on High Prices of Weight Loss Drugs Wegovy and Ozempic in US.
